Clinical Trial Update: A Study of miRNA 371 in Patients With Germ Cell Tumors

View source ↗

Summary

SWOG Cancer Research Network is studying miRNA-371 in patients with germ cell tumors; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Tumor
• Metachronous Malignant Neoplasm
• Seminoma
• Testicular Cancer

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Germ Cell Tumor, Metachronous Malignant Neoplasm | Status: ACTIVE_NOT_RECRUITING